Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
latanoprost (xalatan) (1 trial)
pilocarpine (ocusert) (1 trial)
timolol (blocadren) (1 trial)
Glaucoma, Open-Angle (Phase 4)
Ocular Hypertension (Phase 4)
Trials (1 total)
Trial APIs (3 total)